Skip to main content
Premium Trial:

Request an Annual Quote

Signature Genomics Lab Gets NY State Clinical Lab Permit

NEW YORK (GenomeWeb News) – Signature Genomics Laboratories has received its New York Clinical Laboratory Permit, allowing the firm to receive specimens drawn by clinical laboratories in the state of New York for testing.

The Spokane, Wash.-based firm said today that it is the first laboratory to receive a New York permit to perform microarray-based comparative genomic hybridization. It uses the technology, called SignatureChip, for the genetic evaluation of individuals with unexplained mental retardation and birth defects.

The firm noted that the New York State Clinical Laboratory Permit is issued annually. Signature also holds licenses as an out-of-state clinical lab in Rhode Island, Florida, and California.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.